Press release
Global Factors Driving the Rapid Evolution of the Prostate Cancer Diagnostics Market
Prostate Cancer Diagnostics Market
Forecasted Market Size and Growth Trajectory of the Prostate Cancer Diagnostics Market
The prostate cancer diagnostics market is projected to grow rapidly, reaching a valuation of $9.19 billion by 2030. This reflects a strong compound annual growth rate (CAGR) of 12.9% during the forecast period. The market's expansion is fueled by the progress in molecular and genomic diagnostics, greater adoption of precision oncology methods, broader population screening programs, increasing automation investments, and the rising need for personalized cancer diagnostic solutions. Key trends expected to influence this growth include the uptake of advanced diagnostic assays, biomarker-based testing, integration of AI-assisted imaging, expansion of early detection initiatives, and heightened emphasis on accuracy and risk assessment.
Download a free report of the prostate cancer diagnostics market report:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Prominent Companies Leading the Prostate Cancer Diagnostics Market
Several influential companies shape the landscape of the prostate cancer diagnostics industry. These include F Hoffmann La Roche AG, Bayer AG, Thermo Fisher Scientific Inc, Abbott Laboratories Inc, Siemens Healthineers AG, Becton dic*kinson And Company, Agilent Technologies Inc, Hologic Inc, bioMerieux SA, Beckman Coulter Inc, Qiagen NV, Exact Sciences Corporation, DiaSorin SpA, OPKO Health Inc, Myriad Genetics Inc, Cepheid Inc, NeoGenomics Laboratories Inc, Fujirebio Diagnostics Inc, Ambry Genetics Corporation, MDxHealth SA, Exosome Diagnostics Inc, Cellanyx Diagnostics Inc, A3P Biomedical AB, Roche Diagnostics GmbH, and Sysmex Corporation.
Recent Strategic Acquisitions Expanding Market Capabilities
In October 2024, Trinity Biotech plc, an Ireland-based firm specializing in in vitro diagnostics and diabetes management, acquired Epicapture Limited for an undisclosed sum. This move marked Trinity's entry into the oncology diagnostics space, specifically through adding a non-invasive epigenetic prostate cancer monitoring test to its product offerings. Epicapture Limited is recognized for developing a urine-based epigenetic DNA methylation test designed to evaluate the risk of aggressive prostate cancer, further enhancing Trinity's diagnostic portfolio.
View the full prostate cancer diagnostics market report:
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
How Technological Innovations and AI Are Shaping Market Growth
Leading players in prostate cancer diagnostics are focusing heavily on AI-powered innovations to enhance diagnostic precision and accelerate results. AI-driven diagnostic tools leverage machine learning to detect prostatic adenocarcinoma areas and analyze whole slide images from prostate core needle biopsies, aiding pathologists in achieving faster and more accurate diagnoses. For example, in March 2023, Singapore-based Qritive introduced QAi Prostate, an AI-based diagnostic tool that streamlines workflow, boosts diagnostic accuracy, and shortens timeframes for treatment planning in prostate cancer care.
Market Segmentation Overview of the Prostate Cancer Diagnostics Industry
The prostate cancer diagnostics market is categorized across several dimensions:
1) By Products: Instruments, Reagents and Consumables, Accessories
2) By Test Type: Preliminary Tests, Confirmatory Tests
3) By Prostate Cancer Type: Squamous Cell Cancer, Small Cell Carcinoma, Transitional Cell Cancer, Prostatic Adenocarcinoma, Ductal Adenocarcinoma, Small Cell Prostate Cancer, Acinar Adenocarcinoma
4) By Peer Groups: Adult, Geriatrics
5) By End User: Hospitals, Independent Diagnostic Laboratories, Cancer Research Institutes, Other End Users
Detailed Subcategories Within Product Types
Further breaking down the product segment, instruments include biopsy instruments, imaging devices, and digital rectal examination tools. Reagents and consumables cover diagnostic assay kits, staining reagents, and sample collection materials. Accessories comprise biopsy guides, specimen handling tools, and calibration and maintenance equipment.
This comprehensive segmentation provides a detailed look at the diverse components making up the prostate cancer diagnostics market and highlights its broad scope across products, testing methods, cancer types, demographic groups, and end users.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Factors Driving the Rapid Evolution of the Prostate Cancer Diagnostics Market here
News-ID: 4485994 • Views: …
More Releases from The Business Research Company
Global Drivers Analysis: The Rapid Evolution of the Relapsing-Remitting Multiple …
Relapsing-remitting multiple sclerosis (RRMS) is a critical area of focus within the neurological disorder market, attracting significant attention due to ongoing therapeutic advancements and growing patient needs. This market is poised for steady expansion driven by innovative treatment options and a stronger emphasis on personalized healthcare approaches. Below, we explore the market's forecast, key players, emerging trends, and segmentation in detail.
Projected Market Valuation and Growth Outlook for Relapsing-Remitting Multiple Sclerosis…
Red-Light Whole-Body Panel Plant Market Overview, Key Trends, and Major Player A …
The red-light whole-body panel plant market is poised for significant expansion as demand for therapeutic and wellness devices continues to rise worldwide. With advances in technology and growing consumer interest in health-focused innovations, this sector is set to experience robust growth and evolving trends over the next several years. Let's explore the market's projected valuation, key players, emerging trends, and detailed segment analysis.
Strong Market Growth Expected for the Red-Light Whole-Body…
Segment Analysis and Major Growth Areas in the Real World Evidence Solutions Mar …
The real world evidence solutions market is poised for significant expansion over the coming years, driven by advancements in healthcare data utilization and technological innovation. This sector is becoming increasingly vital as stakeholders seek more accurate and timely insights to improve medical decision-making and patient outcomes. Below, we explore the market's projected growth, key players, emerging trends, and detailed segmentation to provide a comprehensive understanding of this evolving landscape.
Forecasted Growth…
Market Driver Insights: The Impact of Emerging Trends on the Rare Neurological D …
The treatment of rare neurological diseases is gaining increased attention as scientific advancements open new avenues for managing these complex conditions. With breakthroughs in gene therapies, personalized medicine, and clinical research, the market for rare neurological disease treatments is poised for significant expansion in the coming years. Let's explore the current market size, key players, driving factors, emerging trends, and segmentation details shaping this promising sector.
Forecasted Expansion and Market Size…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
